C-Bridge Capital has announced a licensing agreement with Samsung Bioepis that is intended to help the Korean biopharmaceutical specialist expand into the China market.
The private equity firm will establish a new entity, AffaMed Therapeutics, which will collaborate with Samsung Bioepis in areas such as clinical development, regulatory registration and commercialization...
The Overseas Private Investment Corporation (OPIC), a development finance arm of the US government, will invest $185 million in India’s small to medium-sized enterprise sector.
500 Startups has teamed up with a unit of the United Nations to launch an impact-focused start-up accelerator in Indonesia.
Qiming Venture Partners has led a $37 million Series B round for Insilico Medicine, a Hong Kong-based drug development company that uses artificial intelligence (AI).
Texas County & District Retirement System (TCDRS) has committed up to $100 million to Baring Private Equity Asia’s seventh pan-regional fund.